Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Summary

The bill lets a licensed health‑care provider who has established a proper provider‑patient relationship prescribe Schedule II controlled substances through real‑time or approved asynchronous telehealth. It requires the provider to meet the same standard of care as an in‑person visit, disclose their credentials, obtain appropriate consent, and document the encounter. The measure was withdrawn and replaced by A4852.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share